Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
682,156
-
Shares change
-
+14,428
-
Total reported value, excl. options
-
$5,984,000
-
Value change
-
+$128,676
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$8.79
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2017
18 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q4 2017.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 682,156 shares
.
Largest 10 shareholders include HEARTLAND ADVISORS INC (199,600 shares), PERRITT CAPITAL MANAGEMENT INC (154,300 shares), RENAISSANCE TECHNOLOGIES LLC (93,900 shares), SHUFRO ROSE & CO LLC (48,791 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (35,205 shares), Vanguard Group Inc (32,866 shares), Essex Financial Services, Inc. (23,776 shares), WELLS FARGO & COMPANY/MN (23,001 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (16,600 shares), and Minerva Advisors LLC (14,559 shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.